Song, Yongping

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Jiang, Q., Li, Z., Qin, Y., Li, W., Xu, N., Liu, B., Zhang, Y., Meng, L., Zhu, H., Du, X., et al. (2022) · Journal of Hematology & Oncology

Chronic Myeloid Leukemia TreatmentsChronic Lymphocytic Leukemia Research

Cited by 102

Novel immunomodulatory drugs and neo-substrates

Gao, S., Wang, S., & Song, Y. (2020) · Biomarker Research

Protein Degradation and InhibitorsMultiple Myeloma Research and Treatments

Cited by 95

Single VHH-directed BCMA CAR-NK cells for multiple myeloma

Ren, Q., Zu, Y., Su, H., Lu, Q., Xiang, B., Luo, Y., Zhang, J., & Song, Y. (2023) · Experimental Hematology & Oncology

CAR-T cell therapy researchImmune Cell Function and Interaction

Cited by 35

Applications of gut microbiota in patients with hematopoietic stem-cell transplantation

Yu, J., Sun, H., Cao, W., Han, L., Song, Y., Wan, D., & Jiang, Z. (2020) · Experimental Hematology & Oncology

Gut microbiota and healthProbiotics and Fermented Foods

Cited by 25